UniProtKB/Swiss-Prot P24666 : Variant p.Gln106Arg
Low molecular weight phosphotyrosine protein phosphatase
Gene: ACP1
Feedback ?
Variant information
Variant position:
106
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LB/B
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Glutamine (Q) to Arginine (R) at position 106 (Q106R, p.Gln106Arg).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and polar (Q) to large size and basic (R)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Polymorphism:
ACP1 is genetically polymorphic. Three common alleles are known in Caucasians: ACP1*A, ACP1*B and ACP1*C. They give rise to six different phenotypes. Each allele appears to encode two electrophoretically different isozymes, F and S, which are produced in allele-specific ratios (PubMed:1939112 ). The sequence shown is that of allele ACP1*B and allele ACP1*C.
Additional information on the polymorphism described.
Variant description:
In allele ACP1*A.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
106
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
158
The length of the canonical sequence.
Location on the sequence:
FDYILCMDESNLRDLNRKSN
Q VKTCKAKIELLGSYDPQKQL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human FDY---------------ILCMDESNLRDLN---RKSNQ VKTCKAKIEL------------LGSYDPQKQL
Mouse FDY---------------ILCMDESNLRDLN---RKSNQ VK
Rat FDY---------------ILCMDESNLRDLN---RKSNQ VK
Pig FDY---------------ILCMDESNLRDLN---RKGNQ VK
Bovine FDY---------------ILCMDESNLRDLN---RKSNQ VK
Chicken FDY---------------ILCMDESNLRDLK---RKSNQ VK
Slime mold FDY---------------IFAMDESNLSNIKKVLKHSTT KD
Baker's yeast FSYGQDLETYYQTGPGYDVVRSVGANLFNASVKLLKESE VQ
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 158
Low molecular weight phosphotyrosine protein phosphatase
Alternative sequence
78 – 112
ITKEDFATFDYILCMDESNLRDLNRKSNQVKTCKA -> VPSLDLKLCVLCFSGSLTAVLFLTGTWAGPQTQEL. In isoform 4.
Literature citations
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2); VARIANT ARG-106;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.